Are digital therapeutics (DTx) the future of mental health care?

Originally presented at the DTx West 2021 Conference on February 25th 2021.

Join Big Health’s Dr. Jenna Carl, VP of Clinical Development and Medical Affairs as she moderates a panel discussion with Dr. Andrew Krystal of UCSF, Dr. Juliette McClendon from Boston University, Dr. Jordan Silberman from Anthem, and Brian Dolan from Exits and Outcomes, on the importance of clinical evidence to the future of digital therapeutics.

Don’t have time to watch the full video? We got your back. Check out our blog highlighting the key takeaways from the panel.

Watch the presentation

Share article

Here’s our latest

The Impact of Caregiving on Mental Health: Supporting Employees and their Families

According to recent estimates, 1 in 5 US workers serve as family caregivers. Caring for loved ones while balancing workforce…


Navigating the Employee Benefits Ecosystem

Benefits leaders are faced with the unique challenge of expanding access to mental health care by reaching employees in the…


Benefits to Break the Stigma: Addressing caregivers with mental health support

60% of US adults suffer from mental health challenges in silence, due to stigma and other barriers to proper support…


BigHealth Logo

Our mission is to help millions back to good mental health with evidence-based digital therapeutics for the most prevalent mental health conditions. We’re charting the future of digital medicine by providing an inclusive, scalable, and affordable approach based on industry-leading peer-reviewed research and randomized controlled trials. From member engagement to billing via pharmacy benefit managers, we simplify adoption for both payers and patients, improving access to mental health care.

Sign up for expert advice from the Big Health team

Leave a Reply

Your email address will not be published. Required fields are marked *